Windlas Biotech Limited (WINDLAS) reports H1 & Q2 FY27 results with record revenue of Rs. 512 crores, 18% YoY growth, and strong profitability metrics.
Windlas Biotech Limited (WINDLAS) reports a 19% YoY revenue growth to Rs. 264 crore in Q2 FY27, driven by strong performance across all business verticals.
Windlas Biotech Limited (WINDLAS) reports Q1FY27 results with 18% YoY revenue growth to Rs 248 crore, EBITDA up 26%, and PAT up 37%.
Windlas Biotech Limited (WINDLAS) reports Q4 & FY26 results with 18% YoY revenue growth, Rs. 31.60 EPS, and strong net liquidity.